Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04284228
Title Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NexImmune Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.